Sonoma Pharmaceuticals Investor Presentation January 2023

Sonoma Pharmaceuticals presents its commercial and technology progress alongside future financial performance outlook. The presentation covers forward-looking statements regarding regulatory approvals, clinical development, market penetration, and funding requirements for the company's product portfolio.